Matinas Biopharma Holdings, Inc. · AMEX:MTNB
111 Equity Group LLC reported a 4.86% stake in Matinas Biopharma Holdings, Inc. (Schedule 13D)
Event Jan 2, 2025 · Filed Jan 6, 2025
111 Equity Group LLC reported a 4.86% stake in Matinas Biopharma Holdings, Inc., 248,000 shares, with active intent on Jan 2, 2025. Filed Jan 6, 2025 (Schedule 13D).
- Stake
- 4.86%
- Shares
- 248,000
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Chaim Herzog | 5.17% | 263,000 |
| 111 Equity Group LLC | 4.86% | 248,000 |
Source
Related
- Matinas Biopharma Holdings, Inc.
- 111 Equity Group LLC
- Matinas Biopharma Holdings, Inc. shareholders
- Schedule 13D/A · 111 Equity Group LLC · Feb 19, 2025
- Form 4 · Stern Adam K · Aug 13, 2026
- Schedule 13D/A · Stern Adam K · Aug 13, 2026
- Schedule 13G · Hezbay Holdings LLC · Jul 14, 2026
- Schedule 13G/A · Highbridge Capital Management LLC · Nov 14, 2025
- Schedule 13D/A · Hezbay Holdings LLC · Sep 25, 2025